2.  As a medicinal chemist David Woodmansee’s
research in pharmaceutical industry exposed
him to the advantages high-throughput
screening. By quickly sampling thousands of
substances during this process, potential
relationships between medical and drug
components can soon be identified. David H.
Woodmansee, currently of Munich, Germany,
and a former employee of Novartis, knows the
implications of researchers being able to
quickly identify certain areas of drug
composition can rapidly bring advanced
treatments to patients.

3.  When using high-throughput screening,
scientists look for a link between drug
compounds and medically significant
receptors. Libraries containing hundreds of
thousands of these compounds can be sorted
through at a rate of up to 20,000 per week.
Among the libraries currently available to
researchers, there is data on combinatorial
chemistry, genomics, peptides, and proteins for
use in high-throughput screening. Additionally,
the cost for this phase of drug development is
lowered and funds can be shifted to other
stages of the process by using this system of
automation to identify possible reactions.